Evaluation of the pharmacokinetics of 2-carba-cyclic phosphatidic acid by liquid chromatography-triple quadrupole mass spectrometry.

Yoshibumi Shimizu, Keiko Fukasawa, Shinji Yamamoto, Yuki Shibaike, Ryoko Tsukahara, Masaki Ishikawa, Kensuke Iwasa, Keisuke Yoshikawa, Mari Gotoh, Kimiko Murakami-Murofushi

Prostaglandins & other lipid mediators 2020 Oct

filter terms:

Cyclic phosphatidic acid (cPA) is a lysophospholipid mediator that suppresses cancer metastasis and osteoarthritis. It also has neuroprotective roles in diseases such as multiple sclerosis and delayed neuronal death following transient ischemia. In order to take advantage of the properties of cPA for the development of new therapeutic strategies, we have synthesized several cPA derivatives and discovered 2-carba-cPA (2ccPA) as a promising candidate. To develop 2ccPA as a therapeutic agent, we investigated the pharmacokinetic profile of 2ccPA by liquid chromatography-triple quadrupole mass spectrometry in this study. When 2ccPA was administered intraperitoneally to mice at a dose of 1.6 mg/kg, the half-life of 2ccPA in plasma was 16 min. The 2ccPA, dosed intraperitoneally to mice at 16 mg/kg, distributed to each organ including brain at 20 min after dosing. It was found that 2ccPA was stable in neutral or alkaline conditions (e.g., intestine) but unstable in acidic conditions (e.g., stomach). When 2ccPA was orally administrated to rats as a gastro-resistant form using an enterosoluble capsule, plasma 2ccPA levels peaked at 2 h, slowly declined thereafter and persistently detected even at 10 h after administration. Here, we present the findings on the effect of the continuous release of 2ccPA from the capsule to reduce the lysophospholipase D activity and also decrease plasma levels of lysophosphatidic acid in rat. These findings will be useful in further studies for evaluating the application of 2ccPA in several disorders. Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Citation

Yoshibumi Shimizu, Keiko Fukasawa, Shinji Yamamoto, Yuki Shibaike, Ryoko Tsukahara, Masaki Ishikawa, Kensuke Iwasa, Keisuke Yoshikawa, Mari Gotoh, Kimiko Murakami-Murofushi. Evaluation of the pharmacokinetics of 2-carba-cyclic phosphatidic acid by liquid chromatography-triple quadrupole mass spectrometry. Prostaglandins & other lipid mediators. 2020 Oct;150:106450